Cognition Therapeutics, Inc. (CGTX) Net income 2021–2026
Cognition Therapeutics, Inc. (CGTX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$23.5MFY2026 · since FY2021: -$7.8M → -$23.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$23.5M | +30.9% |
| FY2025 | -$34.0M | -31.7% |
| FY2024 | -$25.8M | -20.5% |
| FY2023 | -$21.4M | -82.6% |
| FY2022 | -$11.7M | -49.5% |
| FY2021 | -$7.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CGTX financial trends
CGTX RevenueCGTX Net marginCGTX Gross profitCGTX Gross marginCGTX Operating incomeCGTX Operating marginCGTX Operating cash flowCGTX Free cash flowCGTX Capital expendituresCGTX Return on equityCGTX Stock buybacksCGTX Dividends paidCGTX Total assetsCGTX Total liabilitiesCGTX Shareholders’ equityCGTX overview →